SPOTLIGHT -
EP. 1: Use of AR-V7 as a Prostate Cancer Biomarker
EP. 2: Novel Prostate Cancer Biomarkers
EP. 3: Importance of Molecular Changes in Prostate Cancer
EP. 4: AR Targeted Therapy for Nonmetastatic CRPC
EP. 5: Managing mCRPC Patients on Abiraterone
EP. 6: Early Treatment Approaches in Prostate Cancer
EP. 7: Benefits of Radiopharmaceuticals in mCRPC
EP. 8: Managing Pain in Patients with Prostate Cancer
EP. 9: Monitoring During Radium-223 Treatment in Prostate Cancer
EP. 10: The Role of Sipuleucel-T in Advanced Prostate Cancer
EP. 11: Costs Associated with Prostate Cancer Treatment
EP. 12: Hormone-Sensitive Metastatic Prostate Cancer
EP. 13: Impact of Volume of Disease in Prostate Cancer
EP. 14: Cabazitaxel Use in Metastatic Prostate Cancer
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
